Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of New Magnetic Resonance Methods
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), October 2008
Sponsored by: National Institutes of Health Clinical Center (CC)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001844
  Purpose

This study will evaluate new magnetic resonance imaging (MRI ) methods using a MRI machine more powerful than those in most hospitals. MRI is a diagnostic tool that uses a large magnet and radio waves to produce images of the human body. It can also provide information about brain chemistry and physiology. This study will use the new MRI hardware and methods to measure blood flow and metabolism in regions of the brain during simple tasks, such as listening to tones or watching flashing checkerboards.

Healthy normal volunteers will undergo MRI scanning. For this procedure, the person lies on a stretcher that is moved into a MRI machine, which produces a strong magnetic field. A special lightweight coil is placed on the person's head to obtain better pictures. The scan time ranges from 20 minutes to 2 hours, with the average scan lasting between 45 and 90 minutes. Some persons will be asked to have a contrast agent called gadolinium DTPA injected into their arm through an intravenous catheter (a thin tube placed in a vein). This substance improves scan pictures and is often used in routine MRI brain scans.

During the MRI, the person may be asked to perform simple tasks, such as listening to tones or watching a screen, tapping fingers or moving a hand. More complex tasks may require thinking about tones or pictures and responding to them by pressing buttons.

The images produced in this study will be compared with those produced using standard MRI. The results will be used to develop improved imaging methods for better patient care and research.


Condition
Healthy

MedlinePlus related topics: Nuclear Scans
U.S. FDA Resources
Study Type: Observational
Official Title: Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 Tesla

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 500
Study Start Date: September 1999
Detailed Description:

Technical advances in Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) has provided researchers with the opportunity to study functional and metabolic changes of the central nervous system (CNS) in both healthy controls and individuals with neurological diseases in response to sensory, motor or cognitive stimulation. The NIH has recently acquired a 3.0 Tesla whole body MR unit which has been approved by the Food and Drug Administration for performing functional MR studies. New MRI and MRS techniques and hardware specifically designed for Functional Magnetic Resonance Imaging (fMRI) and Magnetic Resonance Spectroscopic Imaging of the CNS at 3.0 Tesla will be developed, evaluated and compared to similar studies at 1.5 Tesla on normal volunteers and in patients with CNS pathology. These studies are required in order to develop and implement new imaging techniques for research and clinical applications.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • INCLUSION CRITERIA:

Any normal volunteer over 18 years old, which is capable of giving informed consent. For the purpose of evaluating new techniques and hardware for fMRI and MRS, patients will be considered the same as healthy volunteers.

EXCLUSION CRITERIA:

A subject will be excluded if they have contraindications to MR scanning such as the following: Aneurysm clip; Implanted neural stimulator; Implanted cardiac pacemaker or auto-defibrillator; Cochlear implant; Ocular foreign body (e.g., metal shavings); or Insulin pump. Neurological patients will also be excluded from this study. Subjects who have a history of a reaction to MR contrast agents specifically gadopentetate dimeglumine will be excluded from participating in the contrast agent administration part of this protocol. The contraindications to MRI at 1.5 Tesla and 3 Tesla are identical.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001844

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site

Publications:
Study ID Numbers: 990163, 99-CC-0163
Study First Received: November 3, 1999
Last Updated: November 7, 2008
ClinicalTrials.gov Identifier: NCT00001844  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
MRI/MRS
Functional MRI
Metabolic Imaging
Brain
Healthy Volunteer

Study placed in the following topic categories:
Healthy

ClinicalTrials.gov processed this record on January 15, 2009